findmyKOL
Clinical trialNCT06551584RecruitingPhase 1Interventional

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

SponsorStanford UniversityEnrollment24Acute Lymphoid LeukemiaAcute Myeloid LeukemiaMixed Phenotype Acute LeukemiaMyelodysplastic Syndromes
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The study goal is to characterize the safety of the combination of Orca-T with dual agent GVHD prophylaxis.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Stanford University

    Palo Alto, California, United States

    Lori Muffly, MD, MS
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

ORCA-T
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Dec 2025
Primary completion
31 Dec 2026
Completion
31 Dec 2026
Last update posted
23 Jun 2026
Registered enrollment
24
Registry id
NCT06551584
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.